Effects of Bovine a-lactalbumin and Casein Glycomacropeptide enriched Infant Formulae on Faecal Microbiota in Healthy Term Infants
|
|
- Marcus Bishop
- 5 years ago
- Views:
Transcription
1 Journal of Pediatric Gastroenterology and Nutrition 43: # November 2006 Lippincott Williams & Wilkins, Philadelphia Effects of Bovine a-lactalbumin and Casein Glycomacropeptide enriched Infant Formulae on Faecal Microbiota in Healthy Term Infants Wolfram M. Brück, Michele Redgrave, Kieran M. Tuohy, ybo Lönnerdal, zgitte Graverholt, Olle Hernell, and Glenn R. Gibson Food Microbial Sciences Unit, School of Food Biosciences, The University of Reading, Reading, U.K., { Department of Nutrition, University of California, Davis, CA, { Arla Foods Ingredients amba, Viby J, Denmark, and Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden ABSTRACT Objective: Certain milk factors may promote the growth of a host-friendly gastrointestinal microbiota, for example, one that is predominated by bifidobacteria, a perceived healthpromoting genus. This may explain why breast-fed infants experience fewer intestinal infections than their formula-fed counterparts who are believed to have a more diverse microbiota, which is similar to that of adults. The effects of formulas supplemented with 2 such ingredients from bovine milk, a-lactalbumin (a-lac) and casein glycomacropeptide (GMP), on gut flora were investigated in this study. Patients and Methods: Six-week-old (4 8 wk), healthy term infants were randomised to a standard infant formula or 1 of 2 test formulae enriched in a-lac with higher or lower GMP until 6 months. Faecal bacteriology was determined by the culture-independent procedure fluorescence in situ hybridisation. Results: There was a large fluctuation of bacterial counts within groups with no statistically significant differences between groups. Although all groups showed a predominance of bifidobacteria, breast-fed infants had a small temporary increase in counts. Other bacterial levels varied in formula-fed groups, which overall showed an adult-like faecal microflora. Conclusions: It can be speculated that a prebiotic effect for a- lac and GMP is achieved only with low starting populations of beneficial microbiota (eg, infants not initially breast-fed. JPGN 43: , Key Words: Infant nutrition Casein glycomacropeptide Alpha-lactalbumin Fluorescence in situ hybridization Human trials. # 2006 Lippincott Williams & Wilkins INTRODUCTION The human large intestine is a complex ecosystem harbouring a vast range of bacteria (1). To address specific questions on the human gut microbiota, in vitro and in vivo models have been developed. In the in vitro model, an array of techniques have been used, ranging from simple batch culture and screening the fermentative capabilities of specific compounds to more complex continuous culture models (2,3). Such models maintain a microbiota that in many respects is similar to that of the human colon. Hence, the microbial composition of these models have correlated well with in vivo samples and thus allowed the studies of a variety of ecological situations, including the fermentation of Received February 14, 2006; accepted May 25, Address correspondence and reprint requests to Dr Wolfram M. Brück, CAMBio, Letterkenny Institute of Technology, Port Road, Letterkenny, Co Donegal, Ireland ( w_bruck@hotmail.com). both dietary and endogenous substances (4). These models have been extensively applied to various aspects on both probiotic and prebiotic research. However, to more definitively assess the complete functionality and safety of novel food ingredients, in vivo approaches are required (5). Animal models such as human microflora associated rats and neonatal pigs are more able to reflect the complexity of the microbial gut flora in terms of species and numbers, as well as reproducing some biotic parameters such as a mammalian mucosa, immune system and digestive functions. However, subtle differences such as different anatomy and nutrient requirements may put the accuracy of such results in doubt. A more realistic model of the human gut is the use of primates, even though there are logistical and economic problems with this approach. Nevertheless, primates such as baboons and rhesus monkeys have been successfully used in studying novel food ingredients (6 8). These primates also have the advantage of similar nutrient requirements 673
2 674 BRÜCK ET AL. and weaning periods as human infants, thus making them a useful animal model (9). The final assessment of prebiotic effects, however, is to feed candidate substrates or food to human volunteers and assess concomitant microbiological changes in stools (5). Clinical intervention trials have previously been conducted using a wide variety of candidate prebiotics, although the doses, duration of the intervention and number of volunteers have varied. The main drawback with clinical trials is that faeces is the only readily available test material. Therefore, in contrast to in vitro continuous cultures, one cannot assess fermentation results in the proximal colon or metabolic events in the proximal gastrointestinal tract. However, if a candidate prebiotic is able to induce changes in the faecal microbiota or in faecal metabolic factors, then it may be assumed that more saccharolytic environments (eg, the right side of the large gut) are also affected (10). In effect, a randomised placebo-controlled intervention human trial is seen as the ultimate assessment of a candidate prebiotic/probiotic or other food ingredient because it allows researchers to record data from an individual for whom the novel ingredient potentially is intended. Two milk components have previously been shown to modify virulence and stimulate bifidobacteria in vitro while inhibiting gastrointestinal infections in infant rhesus monkeys (6). Casein glycomacropeptide (GMP), a cleavage-product of k-casein, has been shown to prevent haemagglutination by Streptococcus mutans, S. sanguis and Actinomyces viscosus (11). Furthermore, Strömquist et al (12) showed that when sections of formalin-fixed, paraffin-embedded stomach tissue were incubated with purified human k-casein, adhesion of Helicobacter pylori to the tissue was inhibited. In vitro assays also showed that GMP strongly promoted the growth of Bifidobacterium breve, B. bifidum, B. infantis and Lactococcus lactis (13,14). a-lactalbumin (a-lac), which has a tertiary structure comparable to c-type lysozymes, has similar effects (15). Pihlanto-Leppälä et al (16) previously showed that a-lac lowered the metabolic activity of Escherichia coli JM103 to 80% of normal. In addition, the testing of purified cow s milk whey proteins showed that a-lac was a potent growth promoter for B. infantis and B. breve (17). The mechanism behind the effect of a-lac is unclear, but it is speculated that whey products hamper cellular metabolism in a manner similar to that of lactoferrin-derived antibacterial peptides, that is, by affecting the cytoplasmic membrane. In this study, we evaluated the prebiotic effect of a-lac and GMP-supplemented infant formulae in healthy term infants. We tested whether enrichment of standard formula with bovine a-lac and GMP altered the gastrointestinal flora, making it closer to that of breast-fed infants as compared with infants fed control formula. PATIENTS AND METHODS This randomised, double-blinded, placebo-controlled clinical intervention was carried out in Umeå, Sweden, and was approved by the ethics committee of the Faculty of Medicine, Umeå University (Umeå, Sweden). Infant formulae with different levels of GMP and a-lac were provided by ARLA Food Ingredients (Viby, Denmark). Volunteers Healthy term infants ages 6 2 weeks were recruited from well baby clinics in Umeå, Sweden. All infants were exclusively breast-fed from birth and were weaned directly to either one of the study formulas or a standard infant formula for a short time before inclusion in the study. Infants whose parents gave informed written consent were randomised to either (1) a control, commercially available formula (Standard) (11% a-lac, 14% GMP) (n ¼ 17); (2) a formula enriched in a-lac (Alpha-10) (25% a-lac, 15% GMP) (n ¼ 21); or (3) a formula enriched in a-lac but with reduced GMP (PSNU) (25% a-lac, 10% CGMP) (n ¼ 16) (Table 1). Breast-fed infants served as reference (n ¼ 31). The formulae were in powdered form and dry-blended minimize the denaturation of the proteins. All subjects and their parents were in regular contact with the research nurse and had access to 24-h medical advice through the Department of Pediatrics. The intake of either formula or breast milk was ad libitum, and no other food except 1 to 2 tablespoons of fruit purees per day from 4 months of age was allowed during the study. All subjects were free to leave the trial at any time for any reason. Sampling Regime Faecal samples were taken at the start of the study (baseline), at 2 months and at 6 months of age. On the day of sampling, approximately 1 g of fresh faeces was scraped off the draper, placed into an Eppendorf tube and immediately frozen. Samples were stored at 808C and subsequently transported, blind coded, to the University of Reading for further analysis. All faecal material was analysed for predominant populations of the gut microbiota using fluorescence in situ hybridisation (FISH) (6). Sample Preparation Chemical reagents were obtained from Sigma (Poole, UK), unless otherwise stated. Each sample was defrosted, placed in preweighed 50-mL centrifuge tubes and weighed. Phosphatebuffered saline (PBS; 0.1 mol/l), ph 7.4, containing % (wt/vol) cetyltrimethylammonium bromide was added to make a 1:10 (wt/vol) solution. Approximately 6 glass beads (4.5 mm Ø, BDH, Poole, UK) were then added and the samples vigorously vortexed. Three hundred seventy-five microliters of homogenate was then added to 1125 ml of filter-sterile (0.2 mm) 4% (wt/vol) paraformaldehyde in PBS (ph 7.2) and fixed for at least 4 h at 48C (triplicates). The fixed sample was washed twice in 1 ml of filtered PBS (ph 7.4) and pelleted at 13,000g, before
3 EFFECTS OF -LAC- AND GMP-ENRICHED INFANT FORMULAE 675 TABLE 1. Nutrient composition of breast milk and test formulae Nutrients per 100 ml Standard Alpha-10 PSNU Directive Energy (kj) Protein (g) a-lactalbumin (%) Glycomacropeptide (%) Carbohydrate (g) Fat (g) Calcium (mg) Min 33.6 Phosphorus (mg) Sodium (mg) Potassium (mg) Chloride (mg) Magnesium (mg) Iron (mg) Zinc (mg) Copper (mg) Manganese (mg) Iodine (mg) Min 3.36 Selenium (mg) Vitamin A (RE mg) Vitamin D (IU) Vitamin E (IU) Vitamin K (mg) Min 2.8 Vitamin B 1 (mg) Min 28 Vitamin B 2 (mg) Vitamin B 6 (mg) Min 25.2 Vitamin B 12 (mg) Min 0.07 Niacin (mg) Min 168 Vitamin C (mg) Min 5.82 Folic acid (mg) Min 2.8 Pantothenic acid (mg) Min 196 Choline (mg) Biotin (mg) Min 1.12 Inositol (mg) Histidine (mg) Isoleucine (mg) Leucine (mg) Lysine (mg) Methionine (mg) Phenylalanine (mg) Threonine (mg) Tryptophan (mg) Valine (mg) Arginine (mg) Alanine (mg) Aspartic acid (mg) Cysteine (mg) Glutamic acid (mg) Glycine (mg) Proline (mg) Serine (mg) Taurine (mg) Tyrosine (mg) Carnitine (mg) Reference 18. resuspending in 150 ml filtered PBS and 150 ml 96% (vol/vol) ethanol. The sample was mixed and stored at 208C for at least 1 h before analysis by FISH (as previously described) using probes for Lactobacillus, Bifidobacterium, Clostridium, Bacteroides and E. coli and 4 0,6-diamidino-2-phenylindol for total counts (2) (Table 2). Statistical Analysis Statistical analysis was performed using one-way ANOVA for determining significance at P < Variation of the intestinal microflora at the start of the study and after 4 and 6 months was compared for each diet in addition to deviation between diets (Breast Milk Standard formula, Breast Milk PSNU, Breast Milk Alpha-10, PSNU Alpha-10, PSNU Standard, Alpha-10 Standard). Statistical design and analysis was decided on in agreement with the Department of Applied Statistics, The University of Reading, UK. RESULTS Gastrointestinal Symptoms There was no difference in gastrointestinal or other symptoms between the groups (to be reported elsewhere). Parents did not express any concern regarding the formulas used and were generally satisfied. Bacterial Profiles Lactobacillus, Bifidobacterium, Clostridium, Bacteroides and E. coli were quantified using FISH. Breast-fed infants demonstrated a significant increase (P < 0.05) between baseline and 4 months in total counts. Alpha- 10 showed a significant increase in the total bacteria quantified between baseline to 4 months (P < 0.012) and 4 to 6 months of age (P < 0.05). In the PSNU and Standard groups, large but statistically insignificant variations between baseline to 6 months were seen. Average levels of total bacteria decreased slightly by 6 months of age in infants fed PSNU and the breast-fed group. However, this was not statistically significant due to large individual variations within the groups. Bifidobacterium was the predominant population in all infants, and no significant changes in bifidobacteria populations were observed throughout the study in any group, with the exception of breast-fed infants. Breast-fed infants showed a peak of increased bifidobacteria levels at 4 months of age when compared with the other groups. However, levels were again indistinguishable at 6 months. A bifidogenic effect was seen in the percentage difference from baseline to the sixth month (16.8% 50.2%) in the infants fed standard formula with decreased a-lac and increased GMP (Standard formula). However, this did not reach statistical significance, probably due to large individual variations within the group. Lactobacilli levels remained unchanged in all groups throughout the study. Standard formula displayed a dramatic rise in average Clostridium populations (P < 0.039) between baseline and 6 months of intervention. In the percentage-quantified profile, E. coli showed an increase during these 2 time points (4 6 mo), for Alpha-10, but again, due to the large standard deviation, no statistical significance was found. On the whole, Alpha-10 showed
4 676 BRÜCK ET AL. TABLE 2. Genetic probes and sequences used for predominant groups of intestinal bacteria Organism Probe Sequence Bifidobacterium Bif CAT CCG GCA TTA CCA CCC-3 0 Lactobacillus Lac GGT ATT AGC ATC TGT TTC CA-3 0 E. coli Ec CAC CGT AGT GCC TCG TCA TCA-3 0 Clostridium His AAA GGA AGA TTA ATA CCG CAT AA-3 0 Bacteroides Bac TTT CCY TCT AAT TAT GGC GTA TT-3 0 a varied, more adult-like bacterial population (Figs. 1 4). ANOVA analysis showed significant differences in the following bacterial populations: Bacteroides, E. coli, Clostridium and total counts. Infants fed Alpha-10 outperformed all other feeding groups in the fourth month with the lowest bacteroides counts. Significant differences were found between Breast-fed and Alpha-10 (P < 0.03) and Standard and Alpha-10 (P < 0.02) bacteroides populations. PSNU-fed infants displayed similar but not significantly different results (P < 0.07) when compared with infants fed Standard formula and Breast-fed infants. By 6 months of age, average E. coli counts differed significantly in infants that were exclusively breast-fed. Although varying carriage of E. coli amongst the time points and groups was observed, average counts remained most stable only in the breast-fed group (Breast-fed and PSNU, P < 0.032; Breast-fed and Alpha-10, P < 0.03; Breastfed and Standard, P < 0.035). Between the fourth and sixth months, all formula-fed infants showed an increase in Clostridium spp. Breast-fed infants displayed a higher average number of clostridia compared with all of the formula-fed groups at 4 months, with a significant difference in the total number of cells between the breast-fed group and infants fed Alpha-10 (P < 0.047). DISCUSSION In the present double-blinded, randomised, placebocontrolled intervention, we compared the effects of feeding 2 experimental formulas enriched with a-lac, but with 2 different levels of GMP, with feeding a standard formula or breast milk on the gut microflora of healthy infants. No major variation in the Bifidobacterium and Lactobacillus populations of either group of formula-fed infants compared with the breast-fed group was observed. The microflora of the breast-fed infants was stable throughout the study and clearly dominated by bifidobacteria. Furthermore, at 6 months of age, E. coli counts in the breast-fed infants seemed to be stabilised. The breast-fed group also maintained a lower number of total bacteria per gram of faeces compared with the formula-fed groups, which showed increasing average counts of bacteria during the study. In the formula-fed infants, bifidobacteria was also the predominant group and did not vary greatly during the study, except for FIG. 1. Mean bacterial counts in faecal specimens of infants fed standard formula. Mean log 10 per gram weight SD at baseline, 4 months and 6 months. Baseline ¼ point of inclusion in the study; 4 months ¼ 4 months after entrance into trial; 6 months ¼ 6 months after entrance into trial (endpoint).
5 EFFECTS OF -LAC- AND GMP-ENRICHED INFANT FORMULAE 677 FIG. 2. Mean bacterial counts in faecal specimens of breast-fed infants. Mean log10 per gram weight SD at baseline, 4 months and 6 months. Baseline ¼ point of inclusion in the study; 4 months ¼ 4 months after entrance into trial; 6 months ¼ 6 months after entrance into trial (endpoint). infants fed Standard formula. However, in Standard formula fed infants, Bacteroides spp. and Clostridium spp. also varied more. Because all infants had been breast-fed before being recruited into the study, it is possible that a threshold level of bifidobacteria was already established, which prevented further increase in the population. Thus, a prebiotic effect of a-lac and GMP, as observed previously in in vitro cultures (2), may only be seen with low starting populations of beneficial microbiota, for example, in formula-fed infants. This was noted previously by Roberfroid et al. (19), who suggested that a correlation may exist between initial Bifidobacterium spp. population levels and the magnitude of the increase in bifidobacterial numbers in individuals fed prebiotics. Consequently, a dose of a-lac and/or GMP could result in the production of similar high numbers of bifidobacteria irrespective of the initial starting population levels. However, only if the starting population of bifidobacteria is low will a significant increase in cell counts result. A similar explanation could be plausible for lactobacilli. Infants fed Alpha-10 and PSNU formulae displayed FIG. 3. Mean bacterial counts in faecal specimens of infants fed Alpha-10 formula. Mean log10 per gram weight SD at baseline, 4 months and 6 months. Baseline ¼ point of inclusion in the study; 4 months ¼ 4 months after entrance into trial; 6 months ¼ 6 months after entrance into trial (endpoint).
6 678 BRÜCK ET AL. FIG. 4. Mean bacterial counts in faecal specimens of infants fed PSNU formula. Mean log 10 per gram weight SD at baseline, 4 months and 6 months. Baseline ¼ point of inclusion in the study; 4 months ¼ 4 months after entrance into trial; 6 months ¼ 6 months after entrance into trial (endpoint). higher Lactobacillus counts at baseline as did breastfed infants. Thus, no significant changes could be observed because counts were already higher than those of breast-fed infants. It is also interesting to note that PSNU-fed and breast-fed infants had comparable Lactobacillus counts at 6 months of age, even though Alpha-10 fed infants had the highest count of all groups. Another study determined that in formula-fed infants, Bacteroides were found in significantly higher numbers compared with breast-fed infants (20). However, the present study did not show this; all groups displayed variable average Bacteroides counts with both the Standard formula and Breast milk infants having the highest populations at 4 and 6 months. In summary, this study has shown that a formula enriched in a-lac may promote the growth of certain bacterial groups in a manner similar to breast milk. Bifidobacterium levels did not show any substantial difference among groups, but this may reflect the fact that all infants were initially breast-fed. A formula enriched in a-lac and CGMP may promote an intestinal microflora composition closer to that of breast-fed infants. However, due to a high variation of carriage between individuals, it is difficult to draw a firm conclusion on the degree of bifidogenesis induced by either a-lac or GMP because large population fluctuations between single individuals within groups existed. Due to the fact that in previous batch culture and continuous culture models, levels of bifidobacteria were substantial, it may be speculated that enrichment of formula with the 2 milk factors may confer an increase of the indigenous beneficial microflora when levels are below a certain point (ie, below 10% of the faecal flora) (2). Furthermore, it becomes evident that well-controlled human volunteer trials are essential to complete the assessment of new food ingredients because it is virtually impossible to model all aspects of the human colon. Acknowledgments: The study was financially supported by Arla Foods, Viby J, Denmark, and the Swedish Research Council, Medicine. Gitte Graverholt is employed by the main sponsor (Arla Foods). She was involved in discussions regarding study design and contributed to writing the article but did not take part in the analysis or interpretation of data, nor in the decision to write the report and to submit for publication. Wolfram Brück and Michele Redgrave had PhD scholarships paid by the main sponsor. W. Brück did most of the analyses and was the main author of the article. M. Redgrave and K. Tuohy conducted part of the analyses and contributed to data analyses and to writing the article. None of the other researchers had any financial or personal interest in the organizations and companies sponsoring the study. Thus, none of the other authors has any conflict of interest to declare. B. Lönnerdal, O. Hernell and G. Gibson took active part in designing the study, interpreting the data and writing the article. REFERENCES 1. Borriello SP. Microbial flora of the gastrointestinal tract. In: Hill MJ, ed. Microbial Metabolism in the Digestive Tract. Boca Raton, FL: CRC Press Inc, 1986: Brück WM, Graverholt G, Gibson GR. Use of batch culture and a two-stage continuous culture system to study the effect of supplemental alpha-lactalbumin and glycomacropeptide on mixed populations of human gut bacteria. FEMS Microbiol Ecol 2002;41: Brück WM, Graverholt G, Gibson GR. A two-stage continuous culture system to study the effect of supplemental
7 EFFECTS OF -LAC- AND GMP-ENRICHED INFANT FORMULAE 679 alpha-lactalbumin and glycomacropeptide on mixed cultures of human gut bacteria challenged with enteropathogenic Escherichia coli and Salmonella typhimurium. J Appl Microbiol 2003;95: Steer T, Carpenter H, Tuohy K, et al. Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics. Nutr Res Rev 2000;13: Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995;125: Brück WM, Kelleher SL, Gibson GR, et al. rrna probes used to quantify the effects of glycomacropeptide and alpha-lactalbumin supplementation of the predominant groups of intestinal bacteria of infant Rhesus monkeys challenged with enterophathogenic Escherichia coli. J Pediatr Gastroenterol Nutr 2003;37: Brinkley AW, Mott GE. Anaerobic fecal bacteria of the baboon. Appl Environ Microbiol 1978;36: Lindberg T, Engberg S, Jakobsson I, et al. Digestion of proteins in humanmilk, humanmilkfortifier, andpretermformulaininfantrhesus monkeys. J Pediatr Gastroenterol Nutr 1997;24: Kunz C, Lönnerdal B. Protein composition of rhesus monkey milk: comparison to human milk. Comp Biochem Physiol 1993;104A: Tuohy KM, Kolida S, Lustenberger AM, et al. The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructooligosaccharides a human volunteer study. Br J Nutr 2001;86: Neeser JR, Grafström RC, Woltz A, et al. A 23 kda membrane glycomprotein bearing NeuNAca2-3Galb1-3GalNAc O-linked carbohydrate chains acts as a receptor for Streptococcus sanguis OMZ 9 on human buccal epithelial cells. Glycobiology 1995;5: Strömqvist M, Falk P, Bergström S, et al. Human milk k-casein and inhibition of Helicobacter pylori adhesion to human gastric mucosa. J Pediatr Gastroenterol Nutr 1995;21: Bouhallab S, Favrot C, Maubois JL. Growth-promoting activity of tryptic digest of casein glycomacropeptide for Lactococcus lactis subsp lactis. Lait 1993;73: Idota T, Kawakami H, Nakajima I. Growth-promoting effects of N-acetylneuraminic acid-containing substances on bifidobacteria. Biosci Biotechnol Biochem 1994;58: Xue Y, Lui JN, Sun Z, et al. a-lactalbumin mutant acting as lysozyme. Proteins 2001;42: Pihlanto-Leppälä A, Marnila P, Hubert L, et al. The effect of a-lactalbumin and b-lactoglobulin hydrolysates on the metabolic activity of Escherichia coli JM103. J Appl Microbiol 1999;87: Petschow BW, Talbott RD. Response of Bifidobacterium species to growth promoters in human and cow milk. Pediatr Res 1991;29: DHSS. Artificial feed for the young infant. In: Report on Health and Social Subjects. London, UK: HMSO, 1980: Roberfroid MB, Van Loo J, Gibson GR. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 1998;128: Farano S, Chierici R, Guerrini P, et al. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 2003; 91:48 55.
Product Information: EleCare (for Infants)
1 of 5 Product Information: 2 of 5 A 20 Cal/fl oz, nutritionally complete amino acid-based formula for infants who cannot tolerate intact or hydrolyzed protein. EleCare is indicated for the dietary management
More informationProduct Category: EleCare
EleCare Product Category: EleCare EleCare (for Infants) Updated 4/28/2016 Product Information: EleCare (for Infants) 1 of 4 A 20 Cal/fl oz, nutritionally complete amino acid-based formula for infants who
More informationProduct Information: Ketonex -1
Product Information: 1 of 5 Nutrition support of infants and toddlers with maple syrup urine disease (MSUD). Isoleucine-, leucine- and valine-free. Use under medical supervision. Branched-chain amino acid-free
More informationProduct Information: Tyrex -1
Product Information: Tyrex -1 1 of 5 Nutrition support of infants and toddlers with tyrosinemia types I, II or III. Phenylalanine- and tyrosine-free. Use under medical supervision. Phenylalanine- and tyrosine-free
More informationProduct Information: Propimex -1
Product Information: Propimex -1 1 of 5 Nutrition support of infants and toddlers with propionic or methylmalonic acidemia. Methionine- and valine-free; low in isoleucine and threonine. Use under medical
More informationProduct Information: Phenex -1
Product Information: Phenex -1 1 of 5 For nutrition support of infants and toddlers with phenylketonuria (PKU). Phenylalanine-free Use under medical supervision. Phenylalanine-free to allow greater intake
More informationProduct Information: EleCare Jr
Product Information: EleCare Jr 1 of 5 A 30 Cal/fl oz, nutritionally complete amino acid-based medical food for children age 1 and older who cannot tolerate intact or hydrolyzed protein. EleCare Jr is
More informationGOAT MILK OLIGOSACCHARIDES PURIFICATION AND SELECTED BIFIDOBACTERIA CARBOHYDRATE UTILISATION Caroline Thum, PhD student
GOAT MILK OLIGOSACCHARIDES PURIFICATION AND SELECTED BIFIDOBACTERIA CARBOHYDRATE UTILISATION Caroline Thum, PhD student 04/06/2011 Introduction Maternal diet Fermentable oligosaccharides Breast feeding
More informationFood for special medical purposes. phenylketonuria (PKU) Important notice: Suitable only for individuals with proven phenylketonuria.
PKU Nutri 1 Energy Food for special medical purposes. For the dietary management of proven phenylketonuria (PKU) in infants from birth to 12 months and as a supplementary feed up to 3 years. An amino acid
More informationSTANDARD FORMULATED SUPPLEMENTARY SPORTS FOODS
STANDARD 2.9.4 FORMULATED SUPPLEMENTARY SPORTS FOODS Purpose This Standard defines and regulates the composition and labelling of foods specially formulated to assist sports people in achieving specific
More informationQuantity Per Serving. 27 grams
Whey Protein Isolate Nutrient Details Certain nutrients are included or omitted in our Regular Whey Isolate formula for specific reasons backed by scientific research and development Nutrient Type Protein
More informationMSUD HCU Tyrosinaemia MMA/PA IVA (for PKU cooler see pages 11-13)
(for PKU see pages 11-13) + Description A food for special medical purposes. Cooler is a ready-to-drink protein substitute containing essential and non-essential amino acids (but excluding the offending
More informationRecuperation. dog. Getting them back to optimal health has never been this easy. Developed by vets for vets
To obtain optimal recuperation, Viyo Recuperation should be given for at least a period of 14 consecutive days. Developed by vets for vets Recuperation dog Getting them back to optimal health has never
More informationIMPORTANCE OF ALPHA-LACTALBUMIN IN INFANT NUTRITION
IMPORTANCE OF ALPHA-LACTALBUMIN IN INFANT NUTRITION By Dr Dan Alaro Learning Objective Describe the roles of α-lactalbumin as an important nutrients for infants. Protein Composition : Human milk The whey-to
More informationProduct Information: PediaSure Peptide 1.5 Cal
Product Information: PediaSure Peptide 1.5 Cal 1 of 5 PEDIASURE PEPTIDE 1.5 is a nutritionally complete, peptide-based formula for the nutritional needs of children 1-13 years with malabsorption, maldigestion,
More informationProduct Information: Similac Soy Isomil
Product Information: Similac Soy Isomil 1 of 6 A 19 Cal/fl oz, nutritionally complete, soy-based infant formula for infants with feeding problems such as fussiness and gas; for infants whose parents choose
More informationFull Report (All Nutrients) 01174, Milk, reduced fat, fluid, 2% milkfat, without added vitamin A and vitamin D
National base for Standard Reference Release 28 slightly revised May, 206 Full Report (All s) 074, Milk, reduced fat, fluid, 2% milkfat, without added vitamin A and vitamin D Report Date: February 23,
More informationProduct Information: Similac Soy Isomil 20
Product Information: Similac Soy Isomil 20 1 of 6 A 20 Cal/fl oz, nutritionally complete, soy-based infant formula for infants with feeding problems such as fussiness and gas; for infants whose parents
More informationהשפעת חיידקים פרוביוטיים
השפעת חיידקים פרוביוטיים החיים בחלל )המעי(... על רון שאול יחידת גסטרו ילדים מרכז רפואי רמב"ם Introduction The intestinal microflora primarily in the large bowel consists mostly on benign bacterial species
More informationPRO G max Probiotic fermented soybean meal Benefits of PRO G max
PRO G max Probiotic fermented soybean meal Benefits of PRO G max Probiotic bacteria > 10 10 CFU/kg High protein with low molecular weight protein approaching small peptides enhancing digestion and absorption
More informationProduct Information: PediaSure 1.5 Cal with Fiber
Product Information: PediaSure 1.5 Cal with Fiber 1 of 5 PEDIASURE 1.5 CAL WITH FIBER is a higher * caloric density product designed to meet the higher energy requirements of pediatric patients who are
More informationBroiler Nutrition Specifications
Broiler Nutrition Specifications 2 Introduction 3 Table 1: Nutrition Specifications for As-Hatched Broilers - Target Live Weight
More informationNutritional Information
Nutritional Information Honest Milk Step 1 Infant Formula Milk-based Infant Formula Milk powder for Infants 0-12 Months Indication Honest Milk Step 1 Infant Formula Milk Powder Includes Natural Defense
More informationProduct Information: Perative
Product Information: Perative 1 of 5 PERATIVE is designed for metabolically stressed patients who can benefit from an enteral formula supplemented with arginine. For tube feeding. For supplemental or sole-source
More informationProduct Information: Perative
Product Information: Perative 1 of 5 PERATIVE is designed for metabolically stressed patients who can benefit from an enteral formula supplemented with arginine. For tube feeding. For supplemental or sole-source
More informationMicrobial Enhanced Fish Fertilizer Supplement with Vitamins and Nutrients for Plant Health
Microbial Enhanced Fish Fertilizer Supplement with Vitamins and Nutrients for Plant Health INTRODUCTION: MicrobeBio Hydro Activator naturally occurring beneficial organisms, 100% organic proteins, and
More informationProduct Information: Similac Pro-Advance
Product Information: Similac Pro-Advance 1 of 5 SIMILAC PRO-ADVANCE with 2'-FL Human Milk Oligosaccharide * helps strengthen the immune system to be more like the breastfed infant's than ever before. 1,2,3
More informationssniff Complete feeds for rabbits and guinea pigs *
ssniff Complete feeds for rabbits and guinea pigs * Complete diets for all development and life stages Comparable to other animal species also for the breeding and rearing of guinea pigs and rabbits higher
More informationNutramigen with Enflora LGG *
Nutramigen with Enflora LGG * For Cow s Milk Allergy * LGG is a registered trademark of Valio Ltd. Indication Nutramigen with Enflora LGG is an iron-fortified, lactose-free, galactose-free, hypoallergenic
More informationCOMPARISON OF INTERNATIONAL PROTEIN CORPORATION 740 FISH MEAL AND SPECIAL SELECT MENHADEN FISH MEAL IN NURSERY PIG DIETS
Swine Day 2001 Contents COMPARISON OF INTERNATIONAL PROTEIN CORPORATION 740 FISH MEAL AND SPECIAL SELECT MENHADEN FISH MEAL IN NURSERY PIG DIETS M. G. Young, M. D. Tokach, R. D. Goodband, J. L. Nelssen,
More informationProduct Information: Vital AF 1.2 Cal
Product Information: Vital AF 1.2 Cal 1 of 5 VITAL AF 1.2 CAL is Advanced Formula therapeutic nutrition with ingredients to help manage inflammation and symptoms of GI intolerance. For tube or oral feeding.
More informationBROILER. Nutrition Specifications. An Aviagen Brand
BROILER 708 Nutrition Specifications 2014 An Aviagen Brand Introduction Nutrition specifications for Ross 708 broilers are given in the following tables for a range of production and market situations
More informationProduct Category: Perative
Product Category: Perative Perative Updated 4/8/2014 Product Information: Perative 1 of 5 PERATIVE is designed for metabolically stressed patients who can benefit from an enteral formula supplemented with
More informationProduct Category: Amino Acid/Metabolics
Amino Acid/Metabolics Product Category: Amino Acid/Metabolics Calcilo XD Cyclinex -1 Cyclinex -2 Glutarex -1 Glutarex -2 Hominex -1 Hominex -2 I-Valex -1 I-Valex -2 Ketonex -1 Ketonex -2 Phenex -1 Phenex
More informationRanger Gold. Parent Stock NUTRITION SPECIFICATIONS
Ranger Gold Parent Stock NUTRITION SPECIFICATIONS Introduction This booklet contains the nutritional recommendations for Ranger Gold parent stock and is to be used with the Parent Stock Management Handbook
More informationDetox Suite. A collection of premium-quality professional formulas scientifically proven to support the body s natural detoxification mechanisms.
Detox Suite A collection of premium-quality professional formulas scientifically proven to support the body s natural detoxification mechanisms. Features/Use I 3 d Liver Rx Liver Balance DPO FUNCTIONAL
More informationMetabolic Cleanse Delicious Natural Vanilla Flavored Protein Beverage
1 DESCRIPTION Metabolic Cleanse is a unique dietary supplement featuring beneficial amounts of rice, pea and fish proteins synergistically blended with essential amounts of vitamins, minerals, antioxidants
More informationWhey-Grown Yeast as a Protein Source for Baby Pigs
Whey-Grown Yeast as a Protein Source for Baby Pigs Y. J. Ajeani, C. V. Maxwell, F. N. Owens, D. Holbert, K. B. Poling and J. S. Schooley Story in Brief The nutritive value of whey-grown yeast for baby
More informationLeanShake. Key Benefits: ZINZINO
ZINZINO LeanShake Zinzino LeanShake is a delicious and nutritious meal replacement for weight loss 1. Use it to lose fat and build muscles 3, and simultaneously balancing your microbiome, for gut health.
More informationR. O. Gottlob, J. M. DeRouchey, M. D. Tokach, R. D. Goodband, J. L. Nelssen, S. S. Dritz 2, C. W. Hastad, K. R. Lawrence, and D. A.
Swine Day 2004 DETERMINATION OF THE APPARENT AND TRUE ILEAL AMINO ACID DIGESTIBILITY AND DIGESTIBLE AND METABOLIZABLE ENERGY OF SPECIALTY PROTEIN SOURCES INTENDED FOR NURSERY PIG DIETS 1 R. O. Gottlob,
More informationProduct Information: Pivot 1.5 Cal
Product Information: Pivot 1.5 Cal 1 of 5 PIVOT 1.5 CAL is designed for metabolically stressed surgical, trauma, burn, or head and neck cancer patients who could benefit from an immune modulating enteral
More informationOfficial Journal of the European Communities
L 52/19 COMMISSION DIRECTIVE 2001/15/EC of 15 February 2001 on substances that may be added for specific nutritional purposes in foods for particular nutritional uses (Text with EEA relevance) THE COMMISSION
More informationCOMMISSION DIRECTIVE 96/8/EC of 26 February 1996 on foods intended for use in energy-restricted diets for weight reduction. (OJ L 55, , p.
1996L0008 EN 20.06.2007 001.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COMMISSION DIRECTIVE 96/8/EC of 26 February 1996
More informationANNEX. to the COMMISSION REGULATION (EU) /
EUROPEAN COMMISSION Brussels, XXX SANTE/12273/2015 ANNEX (POOL/E4/2015/12273/12273-EN ANNEX.doc) D043783/01 [ ](2016) XXX draft ANNEX 1 ANNEX to the COMMISSION REGULATION (EU) / amending Regulation (EU)
More informationProduct Information: Similac Expert Care Alimentum
Product Information: Similac Expert Care Alimentum 1 of 6 A nutritionally complete, hypoallergenic formula for infants, including those with colic symptoms due to protein sensitivity. A supplemental beverage
More informationSoy Protein. Muscle health benefits: for Sports Nutrition Recovery and during aging. May 9, Mark Cope, PhD
Soy Protein Muscle health benefits: for Sports Nutrition Recovery and during aging May 9, 2017 Mark Cope, PhD Blending Proteins to Provide Better Muscle Health Importance of Muscle Health The Benefits
More informationOfficial Journal of the European Union
L 230/8 EN 25.8.2016 COMMISSION REGULATION (EU) 2016/1413 of 24 August 2016 amending Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods other than those referring
More informationOfficial Journal of the European Union REGULATIONS
L 259/2 REGULATIONS COMMISSION DELEGATED REGULATION (EU) 2017/1798 of 2 June 2017 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional
More informationPregestimil. Pregestimil INDICATION PRODUCT FEATURES. For Fat Malabsorption Problems
Pregestimil For Fat Malabsorption Problems Pregestimil INDICATION Pregestimil is designed for infants who experience fat malabsorption and who may also be sensitive to intact proteins. Fat malabsorption
More informationProduct Information:
Product Information: Pro-Phree 1 of 5 Nutrition support of infants and toddlers who require extra calories, minerals, and vitamins and/or protein restriction. Use under medical supervision. Protein-free
More informationThis document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
2001L0015 EN 11.04.2006 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COMMISSION DIRECTIVE 2001/15/EC of 15 February
More informationLITTLE TREASURE. Premium Australian Made Powdered Milk Products
LITTLE TREASURE Premium Australian Made Powdered Milk Products Little Treasure Infant Formula and other Milk Powder products. Made in Australia to the highest possible standard, using milk from Australian
More informationBacteriology. Mycology. Patient: SAMPLE PATIENT DOB: Sex: MRN: Rare. Rare. Positive. Brown. Negative *NG. Negative
Patient: SAMPLE PATIENT DOB: Sex: MRN: 3.2 0.9-26.8 U/g 1.2 0.2-3.3 mg/g 2.2 1.3-8.6 micromol/g 1.1 1.3-23.7 mg/g 1.1 0.2-3.5 mg/g Rare 1.0 0.2-8.8 mg/g Rare 4.4 2.6-32.4 mg/g 64.6 >= 13.6 micromol/g Bacteriology
More informationLearning from nature for a healthier start Staged infant formulas with Lacprodan mimic the changing protein profile of breast milk
Learning from nature for a healthier start Staged infant formulas with Lacprodan mimic the changing protein profile of breast milk By Lotte Neergaard Jacobsen Arla Foods Ingredients. May 013 1 3 4 www.arlafoodsingredients.com
More informationProduct Information: Similac Pro-Sensitive
Product Information: Similac Pro-Sensitive 1 of 6 Gentle nutrition designed to ease common tummy troubles like fussiness, * gas, * or mild spit-up A 19 Cal/fl oz, nutritionally complete, non-gmo, iron-fortified
More informationThe Gut Microbiome: 101 Justin Carlson University of Minnesota
The Gut Microbiome: 101 Justin Carlson University of Minnesota Where are we now? 360 B.C. 2003 Human Gut Microbes Associated With Obesity Ley et al., Nature. 2006. Consumer Driven Science For Better of
More informationPrebiotic effects of inulin and oligofructose
British Journal of Nutrition (2002), 87, Suppl. 2, S193 S197 q The Authors 2002 DOI: 10.1079/BJN/2002537 Prebiotic effects of inulin and oligofructose S. Kolida*, K. Tuohy and G. R. Gibson Food Microbial
More informationProduct Information: Similac Advance
Product Information: Similac Advance 1 of 5 A 19 Cal/fl oz, nutritionally complete, milk-based, iron-fortified infant formula for use as a supplement or alternative to breastfeeding. OptiGRO is our exclusive
More informationProduct Information: Similac Sensitive NON-GMO
Product Information: Similac Sensitive NON-GMO 1 of 5 A 19 Cal/fl oz, nutritionally complete, non-gmo infant feeding that is an alternative to standard milk-based formulas. Complete nutrition for fussiness,
More informationProduct Information: Similac Alimentum
Product Information: Similac Alimentum 1 of 6 A 20 Cal/fl oz, nutritionally complete, hypoallergenic formula for infants, including those with colic symptoms due to protein sensitivity. A supplemental
More informationThe role of nutrition in optimum gastrointestinal health
The role of nutrition in optimum gastrointestinal health Kelly A. Tappenden, Ph.D., R.D., FASPEN Kraft Foods Human Nutrition Endowed Professor University Distinguished Teacher-Scholar University of Illinois
More informationCOMMISSION DIRECTIVE 96/8/EC. of 26 February on foods intended for use in energy-restricted diets for weight reduction
No L 55/22 ( ENI Official Journal of the European Communities 6. 3. 96 COMMISSION DIRECTIVE 96/8/EC of 26 February 1996 on foods intended for use in energy-restricted diets for weight reduction (Text with
More informationSeppo Salminen Mimi Tang
Koletzko B. (ed): Pediatric Nutrition in Practice. Basel, Karger, 2008, pp 80 84 1 General Aspects of Childhood Nutrition 1.8 Gut Microbiota in Infants Seppo Salminen Mimi Tang Key Words M i c r o b i
More informationProduct Information: Similac Advance 20
Product Information: Similac Advance 20 1 of 7 A 20 Cal/fl oz, nutritionally complete, milk-based, iron-fortified infant formula for use as a supplement or alternative to breastfeeding. No artificial growth
More information7/30/2018. Nutricia North America 1. Learning Objectives
Probiotics, Prebiotics and the Role of the Infant Intestinal Microbiota in Health and Allergic Disease Kelly Tappenden, Ph.D, R.D. Kelly Tappenden, Ph.D, R.D. Professor and Department Head Department of
More informationFor Adults and Children
Goat's Milk: Why it's a Better Choice For Adults and Children What does goat's milk give you that cow's milk doesn't? In many parts of the world, goat s milk is preferred to cow's milk. Even in the United
More informationLeanShake. Key Benefits: ZINZINO
ZINZINO LeanShake Zinzino LeanShake is a delicious and nutritious meal replacement for weight loss 1. Use it to lose fat and build muscles 3, and simultaneously balancing your microbiome, for gut health.
More informationMetabolic Cleanse Delicious Natural Vanilla Flavored Protein Beverage
1 DESCRIPTION Metabolic Cleanse is a unique dietary supplement featuring beneficial amounts of rice, pea and fish proteins synergistically blended with essential amounts of vitamins, minerals, antioxidants
More informationKansas Agricultural Experiment Station Research Reports
Kansas Agricultural Experiment Station Research Reports Volume 0 Issue 10 Swine Day (1968-2014) Article 1092 2004 Determination of the apparent and true ileal amino acid digestibility and digestible and
More informationdiscussing and investigating appropriate formulas before your baby's birth so that you will be well prepared in case of need. Develop your knowledge
NFANT FORMULAS - a parent's guide Vicki Martin - Dietitian Auckland New Zealand Abstract Infant formulas are necessary for babies who are not breastfed and those who are being weaned off the breast. This
More informationIngredients for the next generation
Arla Foods Ingredients Ingredients for the next generation Using infant formulas is second to breastfeeding, a fact supported by WHO. This information is for professional use only. 002 003 Infant nutrition
More informationProduct Category: Pivot 1.5 Cal
Product Category: Pivot 1.5 Cal Pivot 1.5 Cal Updated 4/8/2014 Product Information: Pivot 1.5 Cal 1 of 6 PIVOT 1.5 CAL is designed for metabolically stressed surgical, trauma, burn, and head and neck cancer
More informationROSS 308 AP. Nutrition Specifications PARENT STOCK. An Aviagen Brand
1 PARENT STOCK ROSS 308 AP Nutrition Specifications An Aviagen Brand Introduction This booklet contains the nutritional recommendations for Ross 308 AP (slow feathering) parent stock and is to be used
More informationThe impact of the microbiome on brain and cognitive development
The Gut-Brain Axis The impact of the microbiome on brain and cognitive development Diane Stadler, PhD, RD Oregon Health & Sciences University, Portland, Oregon Lao-American Nutrition Institute With acknowledgements
More informationWHAT S INSIDE. Nutrient Institute LLC. All Rights Reserved
WHAT S INSIDE Nutrient Institute LLC. All Rights Reserved Table of Contents Macronutrients PAGE 3-4 Micronutrients PAGE 5 Other Ingredients PAGE 5-6 Micronutrients PAGE 5 Bad Stuff PAGE 6-8 By Nutrients
More informationProduct Information: PediaSure (Institutional)
Product Information: PediaSure (Institutional) 1 of 5 PediaSure is a source of complete, balanced nutrition especially designed for children 1 to 13 years of age. May be used as the sole source of nutrition
More informationProteins and Amino Acids. Benjamin Caballero, MD, PhD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationInfant formula and formulas for special medical purpose intended for infants
BICS 67.100.10 X 82 National Standard of P.R.C. Substitute for GB10767-1997, GB10765-1997, GB10766-1997 GB Infant formula and formulas for special medical purpose intended for infants (Draft) - - Publish
More informationProduct Category: Child
Child EleCare EleCare Jr Metabolic Cyclinex -1 Cyclinex -2 Glutarex -1 Glutarex -2 Hominex -1 Hominex -2 I-Valex -1 I-Valex -2 Ketonex -1 Ketonex -2 Phenex -1 Pro-Phree Propimex -1 Propimex -2 ProViMin
More informationProduct Information: Similac Special Care 24 High Protein
Product Information: Similac Special Care 24 High Protein 1 of 5 A 24 Cal/fl oz iron-fortified feeding for growing, low-birth-weight infants and premature infants who may need extra protein to help support
More informationDiet and faecal flora in the newborn: casein and whey proteins
Archives of Disease in Childhood, 1989, 64, 1678-1684 Diet and faecal flora in the newborn: casein and whey proteins S E BALMER, P H SCOTF,* AND B A WHARTON Sorrento Maternity Hosptial and *Selly Oak Hospital,
More information10 steps to buying the best protein
10 steps to buying the best protein 1. Ask yourself Do you exercise intensely or often? Then you may need more protein than the average person. Complementing your exercise regime and nutritious diet with
More informationEfficacy of benzoic acid in the feeding of weanling pigs
56th Annual Meeting of EAAP, Uppsala, 5-8 June 2005 Presentation PNPh5.12 Efficacy of benzoic acid in the feeding of weanling pigs D. Torrallardona 1, J. I. Badiola 2 & J. Broz 3 1 IRTA, Centre de Mas
More informationHEMP SEED PROTEIN POWDER
HEMP PROTEIN contains approximately 50% complete plant-based protein, with all 21 known amino acids, including all essential amino acids (that the grown-up human body cannot synthesize itself). Protein
More informationBiacid: A EU approved natural growth promoter for Broilers
Biacid is a blend of calcium salts of organic acids and essential oils. Through the optimal combination of calcium salts of organic acids and essential oils, it enhances broiler microflora within the gut
More informationProduct Category: Vital
Vital Product Category: Vital Vital AF 1.2 Cal Vital High Protein Vital 1.0 Cal Vital 1.5 Cal Updated 4/28/2016 Vital AF 1.2 Cal Therapeutic Nutrition Product Information: Vital AF 1.2 Cal 1 of 5 Vital
More informationProtein Deposition in Growing and Finishing Pigs
1 Protein Deposition in Growing and Finishing Pigs DETERMINING WHOLE BODY PROTEIN DEPOSITION RATES IN PIGS. Mark L. Lorschy, Doug A. Gillis, John F. Patience and Kees de Lange. Summary There is controversy
More informationDetermining the threonine requirement of the high-producing lactating sow. D.R. Cooper, J.F. Patience, R.T. Zijlstra and M.
66 Determining the threonine requirement of the high-producing lactating sow D.R. Cooper, J.F. Patience, R.T. Zijlstra and M. Rademacher Introduction There are two steps in the design of a feeding strategy.
More informationProduct Information: TwoCal HN
Product Information: TwoCal HN 1 of 5 TWOCAL HN is a nutritionally complete, high-calorie formula designed to meet the increased protein and calorie needs of stressed patients and patients requiring low-volume
More informationVITAMINS, MINERALS AND THE GUT
VITAMINS, MINERALS AND THE GUT Nutrients Looking at individual nutrients that are involved with gut health can be misleading This is not about taking individual nutrients It supports more a whole food
More informationHiPP ORGANIC COMBIOTIC. Important building blocks provide for a good start. The new generation of milk formula. omega 3 & 6
For the most in life. HiPP ORGANIC COMBIOTIC Important building blocks provide for a good start (L. fermentum) Information for health care professionals The best food for infants 1 Breast Milk the Gold
More informationProbiotic. Prebiotics:
Probiotic This product has been formulated using a blend of select prebiotics with a wide array of probiotics, designed to naturally strengthen the immune system. The organisms in this formula are synergistic
More informationProduct Information: Nepro with Carb Steady
Product Information: Nepro with Carb Steady 1 of 5 NEPRO WITH CARBSTEADY is therapeutic nutrition specifically designed to help meet the nutritional needs of patients on dialysis (Stage 5 chronic kidney
More informationEmeraid Intensive Care HDN
Emeraid Intensive Care HDN Balanced nutrition for critically ill felines Emeraid Intensive Care HDN Feline or Highly Digestible Nutrition is a semi-elemental therapeutic diet developed by veterinarians
More informationProduct Information: Similac Expert Care NeoSure
Product Information: Similac Expert Care NeoSure 1 of 6 Similac Expert Care NeoSure is designed for babies who were born prematurely. Use under medical supervision. Studies have shown that preterm babies
More information